Az enzimpótló kezelés szerepe a maldigestióval járó pancreasbetegségekben

Translated title of the contribution: The role of enzyme replacement therapy in pancreatic diseases associated with maldigestion

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The pancreas synthesizes and secretes more than 20 digestive enzymes that hydrolyze the major nutritive components, i.e., carbohydrates, fat and protein, within the lumen of the small bowel. In several pancreatic diseases the secretory capacity of the pancreas gradually decreases and the release of pancreatic juice becomes blocked resulting in the characteristic symptoms of maldigestion. Pancreas-associated maldigestion is most often caused by chronic pancreatitis, which can be diagnosed primarily by imaging beside history and clinical symptoms. There is no decisive serological test. The goal of the treatment of pancreatic insufficiency is to reduce symptoms (bloating, abdominal pain, weight loss, and, most importantly, steatorrhea) and improve digestion. One way to do this is to replace pancreatic enzymes. The efficiency of the available enzyme preparations can be increased by the improvement of lipase activity.

Translated title of the contributionThe role of enzyme replacement therapy in pancreatic diseases associated with maldigestion
Original languageHungarian
Pages (from-to)115-122
Number of pages8
JournalLege Artis Medicinae
Volume17
Issue number2
Publication statusPublished - Feb 1 2007

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The role of enzyme replacement therapy in pancreatic diseases associated with maldigestion'. Together they form a unique fingerprint.

  • Cite this